US FDA Would See Cash Windfall In COVID-19 Relief Bill
Executive Summary
The $500m in additional funds would support pandemic-related activities, potentially for additional staff or technology upgrades.
You may also be interested in...
US FDA ‘Quietly Working Hard’ To Develop Advanced Manufacturing Framework
Soon-to-be-released white papers will FRAME how FDA plans assess products manufactured with advanced technologies as part of an initiative to reduce uncertainty for sponsors.
US FDA Program Adds Staff, Graduation Concept To Help Advance Newer Manufacturing Technologies
Agency will expand staffing to address requests for help from its Emerging Technology Program, while “graduating” technologies with which it gains sufficient experience.
Biden Leaves US FDA Largely Out Of Budget Outline
FDA is only mentioned once in the document, and its temporary leadership may not be the reason why.